CYP2E1 and Disorder of lipid metabolism: In addition, magnolol exerts antioxidant activity by inhibiting the liver activity of cytochromeP450, family2, subfamily E, and polypeptide1 (CYP2E1) to improve glucose tolerance, thereby reducing IR and improving glucose and lipid metabolism disorders (Wang et al., 2014).